Solutions
Racial and Ethnic Diversity Plan (REDP) for Clinical Trials to Sponsors Submitting IND/INDA to FDA
Racial and Ethnic Diversity Plans for Biopharmaceutical Companies
FDA has now required biopharmaceutical companies to include a racial and ethnic diversity plan (REDP) in their IND submissions. The FDA has issued guidance to the industry on what is expected in this plan for ensuring all racial and ethnic populations are proportionally represented in their clinical trials across all phases based on the prevalence of the disease under investigation.
Jeeva offers the development and delivery of REDP as a “fee for service” to support our sponsors.
Check our latest Conference on DEIA in Clinical Trials
Driving Global Diversity, Equity, Inclusion, and Access in Clinical Trials: Jeeva’s Vision and Insights Shared at Outsourcing Conference
As an invited speaker, Jeeva founder and CEO outlined his vision for helping sponsors, CROs, and Sites achieve global diversity, equity, inclusion, and access at the outsourcing clinical trials conference in Valley Forge, PA, in May 2023. Dr. Rajasimha also participated in a panel discussion moderated by the rare disease diversity coalition.
Click here to download the presentation “What does it take to truly achieve DEIA in clinical”
Advantages for IITs or ISTs
Features of Jeeva
Works on BYOD Approach (Bring Your Own Device)
Ease of Data Analysis
Customizable and Configurable
Accessible from Various Hardware Devices of Varying Screen Sizes.
Time Saving
Secure Data Storage
Video/Tele/SMS/Email Communications.
Offers Remote Patient Monitoring, Assessments, and Follow-Ups.
Real-Time Live Interactive Communication Options.
Compliance Programs Supported
Testimonials
